This dose-dependent activation was found bilaterally in the ventral mid insula during the peak and early recovery epochs relative to the preinfusion baseline at both 0.5 and 2.0 μg (Figure 4). Potential effects of medication status on the linear mixed-effects models were assessed by generating...